Early research (Phase 1)Active Not RecruitingNCT03374202
What this trial is testing
Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial
Who this might be right for
HIV-1 Infected Adults With Controlled Viremia
National Institute of Allergy and Infectious Diseases (NIAID) 10